Functional characterization and expression of thalamic GABA(B) receptors in a rodent model of Parkinson's disease

Neuropharmacology

Volumn 38, Issue 11, 1999, Pages 1683-1689

  De Groote, C ^a   Wullner U ^a   Loschmann P A ^a   Luiten, P G M ^b   Klockgether, T ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

GABA(B) receptor; In situ hybridisation; Motor behaviour; Parkinson's disease; Thalamus

Indexed keywords

2 HYDROXYSACLOFEN; 3 [1 [3 (CYCLOHEXYLMETHYL)HYDROXYPHOSPHINYL 2 HYDROXYPROPYLAMINO]ETHYL]BENZOIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; 5,5 DIMETHYL 2 MORPHOLINEACETIC ACID; BENZYL[3 [[1 (3,4 DICHLOROPHENYL)ETHYL]AMINO] 2 HYDROXYPROPYL]PHOSPHINIC ACID; MESSENGER RNA; OXIDOPAMINE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; DOSE RESPONSE; GENE EXPRESSION; IN SITU HYBRIDIZATION; INTRACEREBRAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR DENSITY; THALAMUS;

ADRENERGIC AGENTS; ANIMALS; BEHAVIOR, ANIMAL; GABA ANTAGONISTS; MALE; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, WISTAR; RECEPTORS, GABA-B; RNA, MESSENGER; THALAMIC NUCLEI;

EID: 0344069685     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00125-2     Document Type: Article

References (43)

1. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosc. 12:1989;366-375.
2. Badran S., Schmutz M., Olpe H.R. Comparative in vivo and in vitro studies with the potent GABA(B) receptor antagonist, CGP 56999A. Eur. J. Pharmacol. 333:1997;135-142.
3. Bergmann H., Wichmann T., Karman B., DeLong M.R. The primate subthalamic nucleus. II: Neuronal activity in the MPTP model of parkinsonism. J. Neurophysiol. 72:1994;507-520.
4. Bisschof S., Leonhard N., Reymann V., Schuler K., Kaupmann K., Bettler B. Distribution of the GABA-BR1 mRNA in the rat brain. Comparison with GABA-B binding sites. Soc. Neurosc. Abstr. 23:1997;954.
5. Buszáki G. The thalamic clock; emergent network properties. Neuroscience. 41:1991;351-364.
6. Buszáki G., Smith A., Berger S., Fisher L.J., Cage F.-H. Petit mal epilepsy and parkinsonian tremor: hypothesis of a common tremor. Neuroscience. 36:1990;1-14.
7. Caddick S.J., Stanford I.M., Chad J.E. 2-Hydroxysaclofen causes a phaclofen-reversible reduction in population spike amplitude in the rat hippocampal slice. Eur. J. Pharmacol. 274:1995;41-46.
8. Chesselet M.F., Delfs J.M. Basal ganglia and movement disorders: an update. Trends Neurosc. 19:1996;417-422.
9. Churchill L., Zahm D.S., Duffy P., Kalivas P.W. The mediodorsal nucleus of the thalamus in rats: II Behavioral and neurochemical effects of GABA agonists. Neuroscience. 70:1996;103-116.
10. B receptors in excitation and inhibition of thalamocortical cells. Trends Neurosc. 14:1991;16-21.
11. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13:1990;281-285.
12. B receptors. J. Neurosci. 18:1998;9099-9111.
13. DiChiara G., Morelli M., Porceddu M.L., Gessa G.L. Role of thalamic γ-aminobutyrate in motor functions: catalepsy and ipsiversive turning after intrathalamic muscimol. Neuroscience. 72:1979;1453-1465.
14. Emri Z., Turner J.P., Crunelli V. Tonic activation of GABA(B) receptors on thalamic sensory presynaptic afferents. Neuroscience. 72:1996;689-698.
15. Engber G., Nissbrandt H. Gamma-Hydroxybutyric acid (GHBA) induces pacemaker activity and inhibition of substantia nigra dopaminergic neurons by activating GABA(B) receptors. Naunyn-Schmiedebergs Arch. Pharmacol. 348:1993;491-497.
16. Filion M., Tremblay L. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res. 547:1991;142-151.
17. Herkenham H. The afferent and efferent connections of the ventromedial thalamus in the rat. J. Comp. Neurol. 183:1979;487-518.
18. Jenkins I.H., Fernandez W., Playford E.D., Lees A.J., Frackowiak R.S., Passingham R.E., Brooks D.J. Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine. Ann Neurol. 32:1992;749-757.
19. B receptors uncovers similarity to glutamate receptors. Nature. 386:1997;239-246.
20. Kilpatrick I.C., Starr M.S., Fletcher A., James T.A., MacLeod N.K. Evidence for a nigrothalamic pathway in the rat-I behavioral and biochemical studies. Exp. Brain Res. 40:1980;45-54.
21. Klockgether T., Schwarz M., Turski L., Sontag K.-H. Rigidity and catalepsy after injection of muscimol into the ventromedial thalamus: an electromyographic study in the rat. Exp. Brain Res. 58:1985;559-569.
22. Klockgether T., Schwarz M., Turski L., Sontag K.-H. The rat ventromedial thalamus and motor control: role of N-methyl-D-aspartate-mediated excitation, GABAergic inhibition, and muscarinic transmission. J. Neurosci. 6:1986;1702-1711.
23. Klockgether T., Turski L. Towards an understanding of the role of glutamate in experimental Parkinsonism: agonist-sensitive sites in the basal ganglia. Ann. Neurol. 34:1993;585-593.
24. Lang A.E., Lozano A.M. Parkinson's disease. Second of two parts. New Engl. J. Med. 339:1998;1130-1143.
25. Loschmann P.A., Wullner U., Heneka M.T., Schulz J.B., Kunow M., Wachtel H., Klockgether T. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease. Synapse. 26:1997;381-391.
26. MacLeod N.K., James T.A., Kilpatrick I.C., Starr M.S. Evidence for a nigrothalamic pathway in the rat-II. Electrophysiological studies. Exp. Brain Res. 40:1980;55-61.
27. MacLeod N.K., Ryman A., Arbuthnott G.W. Electrophysiological properties of nigrothalamic neurons after 6-hydroxydopamine lesions in the rat. Neuroscience. 38:1990;447-456.
28. Marsden C.D., Obeso J.A. The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's Disease. Brain. 1:1994;517-525.
29. Munoz A., Huntsman M.M., Jores E.G. GABA(B) receptor gene expression in the monkey thalamus. J. Comp. Neurol. 394:1998;118-126.
30. Paré D., Curro'Dossi R., Steriade M. Neural basis of the parkinsonian resting tremor: a hypothesis and its implications for treatment. Neuroscience. 35:1990;217-226.
31. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1998;Academic Press, San Diego.
32. Porter R.H.P., Greene J.-G., Higgins D.S., Greenamyre J.T. Polysynaptic regulation of glutamatergic receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion. J. Neurosci. 14:1994;7192-7199.
33. Richards D.A., Lemos T., Whitton P.S., Bowery N.G. Extracellular GABA in the ventrolateral thalamus of rats exhibiting spontaneous absence epilepsy: a microdialysis study. J. Neurochem. 65:1995;1674-1680.
34. Saywer S.F., Martone M.E., Groves P.M. A GABA immunocytochemical study of rat motor thalamus: light and electron microscopic observations. Neuroscience. 42:1994;103-124.
35. Starr M.S., Summerhayes M. Role of the ventromedial nucleus of the thalamus in motor behaviour-I. Effects of focal injection of drugs. Neuroscience. 10:1983;1157-1167.
36. Starr M.S., Summerhayes M. Role of the ventromedial nucleus of the thalamus in motor behaviour-II. Effects of lesions. Neuroscience. 10:1983;1171-1183.
37. Timmerman W., Westerink B.H.C. Electrical stimulation of the substantia nigra reticulata: detection of neuronal extracellular GABA in the ventromedial thalamus and its regulatory mechanism using microdialysis in awake rats. Synapse. 26:1997;62-71.
38. B antagonists on absences and convulsive seizures. Eur. J. Pharmacol. 13:1997;245-255.
39. Vitek J.L., Asche J., Kaneoke Y. Spontaneous neuronal activity in the motor thalamus: alterations in pattern and rate in parkinsonism. Soc. Neurosc. Abstr. 20:1994;468.
40. Wichman T., DeLong M.R. Functional and pathophysiological models of the basal ganglia. Curr. Opin. Neurobiol. 6:1996;751-758.
41. B receptor mediated hyperpolarization. Neuroscience. 66:1995;133-141.
42. Wüllner U., Klockgether T., Schwarz M., Sontag K.-H. Behavioral actions of baclofen in the rat ventromedial thalamus: antagonism by γ-aminovalerate. Brain Res. 422:1987;129-136.
43. Wüllner U., Standaert D.G., Testa C.M., Penney J.B., Young A.B. Differential expression of kainate receptors in the basal ganglia of the developing and adult brain. Brain Res. 768:1997;215-223.